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Objective: To determine the prevalence of subclinical synovitis using ultrasound (US) imaging of both
painful and asymptomatic joints, in patients with early (,12 months), untreated oligoarthritis ( 5 joints).
Methods: Eighty patients underwent a detailed clinical assessment by two physicians. All painful joints
were identified, which were immediately scanned by a sonographer. In the last 40 patients, an additional
standard group of joints was scanned to establish the prevalence of synovitis in asymptomatic joints.
Results: In 80 patients, 644 painful joints (with and without clinical synovitis) were identified and each
underwent a US assessment. Of these joints, 185 had clinical synovitis, of which, US detected synovitis in
only 79% (147/185). In the other 38 joints US demonstrated tenosynovitis instead of synovitis in 12 joints
and possible, but not definite, synovitis in 11 joints. Fifteen joints were, however, normal on US. In 459
joints that were not clinically synovitic, US detected synovitis in 33% (150/459). In 64% (51/80) of
patients, US detected synovitis in more joints than clinical examination and in 36% (29/80) of patients, US
detected a polyarthritis (.6 joints). Of the 826 asymptomatic (non-painful) joints scanned, 13% (107/
826) had US detected synovitis.
Conclusion: Sonography detected more synovitis than clinical examination in patients with oligoarthritis. In
almost two thirds of patients there was evidence of subclinical disease while one third could be reclassified
as polyarticular. These findings suggest that a definition of oligoarthritis based purely on clinical findings
may be inappropriate, which may have important implications for disease management.
O
ligoarthritis is an inflammatory arthritis char-
acterised by clinical swelling of only a few joints.
Definitions are varied and range from two to four
joints1 or less than six.2 The term encompasses a group
of diseases including reactive arthritis, psoriatic arthritis,
and undifferentiated arthritis,3 in addition to rheumatoid
arthritis (RA) in evolution. Data on outcome in these
patients demonstrate a variable rate of persistence after
conventional treatment.4 5 Currently, no standardised treat-
ment protocol exists, although intra-articular corticosteroids
have recently been shown to be effective in a proportion of
patients.2
Ultrasonography (US) is an increasingly used technique
by clinicians for the evaluation of inflammatory joint
diseases.6–10 It has been shown to be sensitive in the
detection of synovitis and bone erosion in both small and
large joints.11–18 It has several advantages over magnetic
resonance imaging (MRI), including cost, immediate avail-
ability in the clinic, and the ability to scan multiple joints at
one time.
One reason for the variability in outcome in patients with
oligoarthritis is the heterogeneity of the population given that
the diagnosis is based only on the number of joints with
clinical synovitis. The prevalence of subclinical disease in
these patients is unknown and may qualitatively alter
subsequent outcome as well as defining a group of patients
requiring more aggressive treatment.
This study aimed at determining the prevalence of
subclinical synovitis defined by US in patients with early,
untreated oligoarthritis. The ultrasonographer, unaware of
the clinical findings, scanned all painful joints. Additionally,
in the final 40 patients, a standard set of joints was scanned
to determine the prevalence of synovitis in asymptomatic
joints.
METHODS
Patients
This study received Leeds General Infirmary ethical commit-
tee approval and all patients gave written informed consent.
Patients with early oligoarthritis (,12 months symptoms)
were recruited consecutively from the early arthritis clinics
within the Yorkshire region. Oligoarthritis was defined as the
presence of clinical synovitis in (5 joints. Clinical synovitis
required the fulfilment of at least two of the following three
criteria: swelling, tenderness, or decreased range of move-
ments of any peripheral joint (excluding a distal inter-
phalangeal joint). The last criterion allowed the inclusion of
the deeper joints such as the shoulder, where the usual signs
of synovitis, in particular swelling, are difficult to elicit. All
patients had stopped their non-steroidal anti-inflammatory
drugs three days before entry and all were corticosteroid and
disease modifying antirheumatic drug naı¨ve.
Ultrasound evaluation
Ultrasonography was performed with an ATL HDI 3000
machine with a 10–5 MHz linear ‘‘hockey stick’’ transducer
(Advanced Technologies Laboratories, Bothel, Washington,
USA). All scans were performed by a rheumatologist (RJW)
specifically trained in joint sonography. Gel was applied to
the skin to provide an acoustic interface.
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rheumatoid factor; US, ultrasound
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Definit ion of ultrasonographic synovitis and method
of scoring
Synovitis was defined as the presence of an abnormally
hypoechoic joint space reflecting synovial hypertrophy,
distinct from the intra-articular fat pad and non-compres-
sible with the transducer. Synovial fluid was detected by the
presence of an abnormally anechoic space within the joint,
which was compressible. Joint examination technique
followed the EULAR guidelines,19 and all findings were
interpreted using both longitudinal and transverse planes.
Synovitis was scored as either definitely present (1) or absent
(0). The presence of bone erosions (cortical defect seen in two
or more scanning planes), tenosynovitis (abnormally hypo-
echoic area around tendon seen in longitudinal and
transverse planes), or other soft tissue abnormalities was
also documented.
Study design
At presentation, each patient underwent a detailed clinical
history and examination to identify all joints, which were
currently (,1 week) painful (symptomatic). Two clinicians
(MJG, PE) then examined these joints for the presence of
clinical synovitis as previously defined and a consensus was
reached between them. The clinical assessment was followed
by a general laboratory screen including full blood count,
erythrocyte sedimentation rate, plasma viscosity, C reactive
protein, biochemical profile, rheumatoid factor (RF), anti-
nuclear antibody, urate, immunoglobulin and HLA-DRB1*01/
DRB1*04 and HLA-B27 as well as appropriate microbiological
and radiological investigations (including radiographs of the
chest, hands, and feet in all patients).
A list of all painful joints was then given to the
sonographer (RJW) who immediately scanned each joint
for the presence of definite synovitis. After scanning the first
40 patients it became apparent that subclinical disease was
very common and we therefore questioned whether synovitis
might occur in asymptomatic joints. The protocol was
therefore subsequently modified so that in the final 40
patients, a standard group of 22 joints was scanned (10
metatarsophalangeal (MTP) joints, 10 metacarpophalangeal
(MCP) joints, 2 knees), irrespective of symptoms or signs, in
addition to all symptomatic joints. The sonographer was
unaware of which joints were either symptomatic or
asymptomatic.
Statistics
The number of joints with clinical synovitis or US detected
synovitis was not normally distributed and therefore the
means, medians, and ranges were reported. Differences
between patients with subclinical and no subclinical disease
were measured by either the x2 test or Fisher’s exact test, as
appropriate.
RESULTS
Eighty patients were recruited into the study. Table 1 gives
the patient demographic data.
Clinical findings
In total, 1470 joints were clinically examined, of which 644/
1470 (44%) were painful and 826/1470 (56%) were asympto-
matic (non-painful and not swollen). Clinical synovitis was
found in 185/1470 (12.6%) joints examined: knee joints 52/
185 (28%), MTP joints 29 (16%), MCP joints 21 (11%),
proximal interphalangeal (PIP) joints 21 (11%), ankles 19
(10%), wrists 18 (10%), elbows 5 (3%), shoulders 3 (2%),
miscellaneous other joints 17 (9%). Figure 1 shows the
number of clinically swollen joints/patient. The mean and
median number of clinically synovitic joints/patient was 2
(range 1–5). Twenty six patients had a monarthritis (14
knees, 8 ankles, 4 wrists), 52 patients had synovitis in two to
four joints, but only two patients had synovitis in five joints.
Ultrasound findings
The mean and median number of joints/patient with US
synovitis was five and four joints respectively (range 1–28).
Figure 2 shows the frequency distribution of the number of
joints with US detected synovitis. The frequency of joint types
with US synovitis (n = 404) was: MTP joints 195 (48%), MCP
joints 65 (16%), knees 65 (16%), wrists 30 (7%), ankles 22
(5%), PIP joints 25 (6%). US detected synovitis was found in
32/35 (91%) clinically swollen MTP joints.
Table 1 Patient characteristics
Characteristics
No of patients 80
Age (years), mean (range) 37.4 (20–81)
Women, No (%) 39 (49)
Disease duration (weeks), mean (range) 18 (2–52)
Monarthritis, No (%) 26 (33)
Number of swollen joints, mean (range) 2 (1–5)
CRP .100 g/l, No (%) 54 (68)
RF .40 IU/l, No (%) 12 (15)
DR4 and/or DR1, No (% of tested) 47/71 (66)
HLA-B27, No (% of tested) 18/76 (24)
RF, rheumatoid factor; CRP, C reactive protein.
Figure 1 Number of patients (n = 80) with swollen joints (n = 185) as
detected by clinical examination.
Figure 2 Number of patients with US
detected synovitis in different numbers
of joints.
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US synovitis in symptomatic joints (fig 3)
US documented synovitis in 147/185 (79%) clinically syno-
vitic joints. All clinically synovitic joints were painful. In the
other joints that were painful but not clinically synovitic, US
detected synovitis in 150/459 (33%) joints (fig 4).
Clinical examination detected more synovitis than US in 38
joints because US demonstrated tenosynovitis instead of
synovitis in 12 joints (6 wrists, 3 ankles, 3 MCP joints) and
possible, but not definite, synovitis in 11 joints (3 wrists, 3
ankles, 2 knees, 3 MTP joints). However, 15 joints with
clinical synovitis were recorded as normal on US (4 wrists, 4
ankles, 3 knees, 3 MTP joints, 1 interphalangeal (IP) joint).
This change in joint number, however, did not equate to a
change in the number of patients with synovitis. Of the 26
patients who had a monarthritis based on clinical examina-
tion, 11/26 (42%) corresponded exactly with US, 9/26 (35%)
had US synovitis in .1 joint (2–12), and 6/26 (23%) had US
synovitis defined polyarthritis (>6 joints).
US detected synovitis in asymptomatic joints (fig 3)
In total, 826/1470 (56%) of joints scanned were clinically
asymptomatic (non-painful and not swollen). Of these
clinically normal joints, 13% (107/826) had evidence of
subclinical synovitis. Of the 107 asymptomatic joints, which
had US detected subclinical disease, 85 (79%) were MTP
joints, 17 (16%) MCP joints, and 5 (5%) knees. Only seven
patients had subclinical disease in one additional joint, which
consisted of 5 MTP joints (4 were a 1st MTP joint) and 2
knees.
Characteristics of patients with subclinical disease
Table 2 gives the patient characteristics of those with and
without subclinical disease. No statistically significant
differences in sex, age, CRP, RF, DR4 and/or DR1, or
HLA-B27 status existed between the groups, although there
was a trend towards those with subclinical disease being
more likely to be RF or HLA-B27 positive. The prevalence
of subclinical and polyarticular disease was also assessed
according to baseline diagnosis (table 3). For the patient
groups, 18 patients in the first 40 patients had subclinical
disease and 33 in the second set of 40. This may reflect the
greater number of joints scanned in the second group (997
joints versus 473).
DISCUSSION
This study highlights for the first time, a high prevalence of
subclinical synovitis defined by US in patients with early,
untreated oligoarthritis and the relative insensitivity of
clinical examination. It suggests that two thirds of patients
have subclinical disease and about one third could be
reclassified as having a polyarticular disease. In painful
joints, US detected synovitis in 79% of those with clinical
synovitis and 33% joints without synovitis. The prevalence of
synovitis in asymptomatic joints was 13%.
Ultrasound represents a safe and relatively inexpensive tool
for joint examination and is ideally suited for multiple joint
assessment. In contrast, traditional MRI is more expensive
and time consuming and is limited to predesignated
anatomical areas at the time of scanning, while isotope bone
scans expose the patient to ionising radiation and are less
pathologically specific.
Previous imaging studies using US15–18 have demonstrated
the inaccuracy of clinical examination at detecting joint
inflammation. Our study highlights that in this cohort of
patients with early inflammatory arthritis, synovitis may
occur in both painful (but not clinically synovitic joints) and
asymptomatic joints. Arthroscopic evidence from patients
with RA has previously shown that asymptomatic knee
synovitis is common in patients with both active, untreated
Figure 3 Prevalence of US detected synovitis in joints which were
asymptomatic (n = 826), clinically painful but not swollen (n = 425), and
clinically synovitic joints (n = 185).
Figure 4 (A) Longitudinal US image through a non-painful MTP joint demonstrating no evidence of synovitis. M, metacarpal head; P, base of
proximal phalanx; *normal intra-articular fat pad. (B) Longitudinal US image through a painful but not clinically synovitic MTP joint demonstrating
synovitis (S) and loss of definition of normal intra-articular fat pad. M, metacarpal head; P, base of proximal phalanx.
Table 2 Comparison of demographic and laboratory
data between patients with or without subclinical disease
Subclinical
disease
(n = 51)
No subclinical
disease
(n = 29) Significance
Female sex, No (%) 19/51 (37) 20/29 (67) NS
Age (years), mean 36 38 NS
CRP .100 g/l, No (% of
tested)
34/51 (67) 20/29 (67) NS
RF .40 IU/l, No (% of
tested)
10/51 (20) 2/29 (7) NS
DR4 and/or DR1, No (%) 26/51 (51) 21/29 (72) NS
HLA-B27, No (%) 15/51(29) 3/29 (10) NS
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early disease20 and chronic disease.21 In addition, Kraan et al
have demonstrated in rhesus monkey models of RA that
subclinical disease does precede clinical disease in prospective
studies.22 This may account for the observation that many
patients with RA already have signs of joint destruction by
the time of presentation.23
Pando et al, with an arthroscopy study, suggested that
patients with reactive arthritis were less likely to have
subclinical disease than other forms of inflammatory
arthritis.24 In our study, however, 14 patients had proven
reactive arthritis at baseline; of these, 50% (7/14) had
evidence of subclinical disease and 30% had polyarticular
disease. The different results by Pando et al may reflect
smaller patient numbers or prior treatment with disease
modifying drugs.
There are several limitations to our study. Firstly, we did
not validate the additional synovitis by other imaging
techniques—for example, arthroscopy, MRI, or isotope bone
scanning. However, these techniques are limited by either an
inability to scan more than one joint or a lack of specificity.
Secondly, we are aware that a healthy control group
scanned randomly with the oligoarthritis patients would
have strengthened the study. However, our own depart-
mental data on asymptomatic hospital workers has demon-
strated a low prevalence of synovitis—occurring in ,5% of
MTP joints, MCP joints, and knees. Thirdly, the scanning
process was time consuming taking about about 35 minutes/
patient (range 20–50). This may, however, have overesti-
mated the time required as this included time for detailed
documentation within the setting of a clinical study.
In summary, this study for the first time describes the US
phenotype of patients with early, treatment naı¨ve, ‘‘oligo-
arthritis’’. It highlights the relative insensitivity of routine
clinical examination and demonstrates that subclinical
synovitis as detected by US is common in these patients. A
definition of oligoarthritis, therefore, based purely on clinical
examination alone may be inappropriate and indicates that
true oligoarthritis is a much rarer phenomenon. The findings
of this study may have important implications for disease
management by potentially allowing prediction of persistence
and prognosis of those patients. Longitudinal assessment is,
however, required to determine the true significance of
subclinical disease.
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